OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS: MODELING PREVENTION OF CLINICAL EVENTS USING REAL-WORLD DATA

被引：0
|
作者：
Younossi, Z. M. [1 ]
Ellis, A. [2 ]
Lee, J. [3 ]
Bessonova, L. [4 ]
Nair, R. [4 ]
Potente, E. [4 ]
Gish, R. G. [5 ]
机构：
[1] Global Liver Council, Ctr Outcomes Res Liver Dis, Washington, DC USA
[2] Stratevi, Boston, MA USA
[3] Stratevi, Santa Monica, CA USA
[4] Intercept Pharmaceut, Morristown, NJ USA
[5] Robert G Gish Consultants LLC, San Diego, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD140
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [21] REAL-WORLD DATA ON LONG TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS: FIRST RELEASE FROM THE ITALIAN RECAPITULATE STUDY
    De Vincentis, Antonio
    Terracciani, Francesca
    D'Amato, Daphne
    Invernizzi, Pietro
    Morgando, Anna
    Vanni, Ester
    Vigano, Mauro
    Alvaro, Domenico
    Venere, Rosanna
    Lleo, Ana
    Colapietro, Francesca
    Degasperi, Elisabetta
    Vigano, Raffaella
    Giannini, Edoardo G.
    Labanca, Sara
    Feletti, Valentina
    Mussetto, Alessandro
    Cozzolongo, Raffaele
    Losito, Francesco
    Pompili, Maurizio
    Ponziani, Francesca Romana
    Niro, Grazia Anna
    Cotugno, Rosa
    Pozzoni, Pietro
    Chessa, Luchino
    Cuccorese, Giuseppe
    Palitti, Valeria Pace
    Russello, Maurizio
    Cannavo, Mariarita
    Frazzetto, Evelise
    Bertino, Gaetano
    Marzioni, Marco
    Terreni, Natalia
    Zolfino, Teresa
    Saitta, Carlo
    Pellicelli, Adriano
    Coco, Barbara
    Brunetto, Maurizia
    Cazzagon, Nora
    Floreani, Annarosa
    Muratori, Luigi
    Rosina, Floriano
    Di Stefano, Marco
    Scifo, Gaetano
    Baiocchi, Leonardo
    Grassi, Giuseppe
    Sacco, Rodolfo
    Izzi, Antonio
    Croce, Saveria Lory
    Fiorini, Cecilia
    HEPATOLOGY, 2023, 77 (05) : E137 - E139
  • [22] REAL-WORLD CLINICAL SIGNIFICANCE OF BIOCHEMICAL RESPONSE AND LIVER STIFFNESS VARIATION OVER TIME IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID
    De Vincentis, Antonio
    Terracciani, Francesca
    D'Amato, Daphne
    Invernizzi, Pietro
    Vanni, Ester
    Campion, Daniela
    Floreani, Annarosa
    Cazzagon, Nora
    Alvaro, Domenico
    Giannini, Edoardo
    Labanca, Sara
    Lleo, Ana
    Colapietro, Francesca
    Degasperi, Elisabetta
    Vigano, Mauro
    Pesatori, Eugenia
    Fagiuoli, Stefano
    Marzioni, Marco
    Vigano, Raffaella
    Galli, Andrea
    Marra, Fabio
    Begini, Paola
    Baiocchi, Leonardo
    Muratori, Luigi
    Coco, Barbara
    Brunetto, Maurizia
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Falbo, Elisabetta
    Surace, Lorenzo
    Mattalia, Alberto
    Ieluzzi, Donatella
    Salomone, Fderico
    Delle Monache, Giulio
    Tatonetti, Riccardo
    Cavalli, Ilaria
    Cossiga, Valentina
    Morisco, Filomena
    Valiani, Vincenzo
    Boccaccio, Vincenzo
    Angrisani, Debora
    Vettori, Giovanni
    Cuffari, Biagio
    Moretti, Alessandra
    Rocco, Alba
    Nardone, Giovanni
    Scivetti, Paolo
    Costanzo, Martina
    Boano, Valentina
    Manfredi, Giulia Francesca
    HEPATOLOGY, 2024, 80 : S1780 - S1782
  • [23] Primary biliary Cholangitis: Obeticholic Acid as Monotherapy?
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (09): : 1043 - 1043
  • [24] Obeticholic acid for the treatment of primary biliary cholangitis
    Ali, Ahmad H.
    Lindor, Keith D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1809 - 1815
  • [25] Obeticholic acid monotherapy for primary biliary cholangitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 852 - 852
  • [26] Obeticholic Acid in Primary Biliary Cholangitis REPLY
    Nevens, Frederik
    Lindor, Keith D.
    Jones, David E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20):
  • [27] Obeticholic Acid (Ocaliva) for Primary Biliary Cholangitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1517): : 53 - 55
  • [28] Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort
    Terracciani, Francesca
    De Vincentis, Antonio
    D'Amato, Daphne
    Scaravaglio, Miki
    Invernizzi, Pietro
    Vanni, Ester
    Campion, Daniela
    Floreani, Annarosa
    Cazzagon, Nora
    Alvaro, Domenico
    Venere, Rosanna
    Giannini, Edoardo
    Labanca, Sara
    Lleo, Ana
    Colapietro, Francesca
    Degasperi, Elisabetta
    Vigano, Mauro
    Pesatori, Eugenia Vittoria
    Fagiuoli, Stefano
    Marzioni, Marco
    Buzzanca, Valerio
    Vigano, Raffaella
    D'Amico, Federico
    Galli, Andrea
    Curto, Armando
    Marra, Fabio
    Begini, Paola
    Baiocchi, Leonardo
    Carni, Paola
    Muratori, Luigi
    Coco, Barbara
    Brunetto, Maurizia
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Falbo, Elisabetta
    Surace, Lorenzo
    Mattalia, Alberto
    Ieluzzi, Donatella
    Salomone, Federico
    Delle Monache, Guido
    Tatonetti, Riccardo
    Cavalli, Ilaria
    Cossiga, Valentina
    Morisco, Filomena
    Valiani, Vincenzo
    Gatti, Pietro
    Boccaccio, Vincenzo
    Angrisani, Debora
    Vettori, Giovanni
    Cuffari, Biagio
    JOURNAL OF HEPATOLOGY, 2024, 80 : S96 - S97
  • [29] Long-term, real-world outcomes under obeticholic acid treatment in primary biliary cholangitis: a nationwide multicentre study
    Abbas, Nadir
    Almahroos, Amal
    Smith, Rachel
    Culver, Emma
    Thorburn, Douglas
    Halliday, Neil
    Dyson, Jessica
    Mells, George F.
    Jones, David E.
    Trivedi, Palak J.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S290 - S291
  • [30] Effectiveness of obeticholic acid in patients with primary biliary cholangitis stratified by biochemical marker status in the real-world setting in the United States
    Gish, Robert G.
    Wheeler, Darren
    Lin, Jay
    Adekunle, Femi
    Lingohr-Smith, Melissa
    Bassanelli, Chiara
    Law, Amy
    JOURNAL OF HEPATOLOGY, 2021, 75 : S424 - S425
12345